Ludmilla Malveira Lima Lopes1, Rossana Pulcineli Vieira Francisco2, Marco Aurélio Knippel Galletta3, Marcello Delano Bronstein4. 1. Neuroendocrine Unit, Division of Endocrinology and Metabolism, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil. ludmillamalveira@hotmail.com. 2. Department of Obstetrics and Gynecology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil. rossana.francisco@hc.fm.usp.br. 3. Department of Obstetrics and Gynecology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil. mgalletta@uol.com.br. 4. Neuroendocrine Unit, Division of Endocrinology and Metabolism, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, SP, Brazil. mdbronstein@uol.com.br.
Abstract
PURPOSE: Nighttime salivary cortisol (NSC) has been proposed for the diagnosis of Cushing's syndrome during pregnancy. However, reference values for NCS in pregnant women have not been adequately determined. The aim of this study was to determine the reference values of NSC in the three gestational trimesters in order to help distinguish physiological from pathological hypercortisolism during pregnancy. METHODS: This prospective and retrospective study evaluated 85 pregnant women in whom samples were collected in the first, second and/or third gestational trimester (pregnancy group), 33 non-pregnant women (control group), and 25 non-pregnant women with Cushing's disease (CD group). NSC was measured by enzyme-linked immunosorbent assay. RESULTS: NSC increased progressively during pregnancy, reaching maximum levels on the third trimester (median 2.1-fold increase compared with controls, p < 0.001). Reference values for NSC were determined and the upper limits on each gestational trimester were: first trimester 0.25 µg/dL (6.9 nmol/L), second trimester 0.26 µg/dL (7.2 nmol/L), and third trimester 0.33 µg/dL (9.1 nmol/L). Cutoff values that separated the CD group from the three trimesters in the pregnancy groups were, respectively, 0.255 µg/dL (7.0 nmol/L), 0.260 µg/dL (7.2 nmol/L), and 0.285 µg/dL (7.9 nmol/L). Comparison of NSC cutoff values in pregnant women with CD patients showed high sensitivity and specificity in all three trimesters. CONCLUSIONS: We established cutoff values for determination of NSC which can be useful for pregnant women with a diagnostic suspicion of CD.
PURPOSE: Nighttime salivary cortisol (NSC) has been proposed for the diagnosis of Cushing's syndrome during pregnancy. However, reference values for NCS in pregnant women have not been adequately determined. The aim of this study was to determine the reference values of NSC in the three gestational trimesters in order to help distinguish physiological from pathological hypercortisolism during pregnancy. METHODS: This prospective and retrospective study evaluated 85 pregnant women in whom samples were collected in the first, second and/or third gestational trimester (pregnancy group), 33 non-pregnant women (control group), and 25 non-pregnant women with Cushing's disease (CD group). NSC was measured by enzyme-linked immunosorbent assay. RESULTS: NSC increased progressively during pregnancy, reaching maximum levels on the third trimester (median 2.1-fold increase compared with controls, p < 0.001). Reference values for NSC were determined and the upper limits on each gestational trimester were: first trimester 0.25 µg/dL (6.9 nmol/L), second trimester 0.26 µg/dL (7.2 nmol/L), and third trimester 0.33 µg/dL (9.1 nmol/L). Cutoff values that separated the CD group from the three trimesters in the pregnancy groups were, respectively, 0.255 µg/dL (7.0 nmol/L), 0.260 µg/dL (7.2 nmol/L), and 0.285 µg/dL (7.9 nmol/L). Comparison of NSC cutoff values in pregnant women with CDpatients showed high sensitivity and specificity in all three trimesters. CONCLUSIONS: We established cutoff values for determination of NSC which can be useful for pregnant women with a diagnostic suspicion of CD.
Authors: Kalyani Sridharan; Jayaprakash Sahoo; Rajan Palui; Milind Patil; Sadishkumar Kamalanathan; A S Ramesh; N S Kubera Journal: Pituitary Date: 2021-03-29 Impact factor: 4.107
Authors: A Scutelnicu; A M Panaitescu; A M Ciobanu; N Gica; R Botezatu; G Peltecu; M L Gheorghiu Journal: Acta Endocrinol (Buchar) Date: 2020 Oct-Dec Impact factor: 0.877
Authors: Cindy K Barha; Katrina G Salvante; Courtney W Hanna; Samantha L Wilson; Wendy P Robinson; Rachel M Altman; Pablo A Nepomnaschy Journal: PLoS One Date: 2017-05-25 Impact factor: 3.240